E2F1 enhances 8-Chloro-adenosine-induced G2/M arrest and apoptosis in A549 and H1299 lung cancer cells

被引:0
作者
Hong-Ying Duan
Ji-Xiang Cao
Jun-Juan Qi
Guo-Sheng Wu
Shu-Yan Li
Guo-Shun An
Hong-Ti Jia
Wang-Wei Cai
Ju-Hua Ni
机构
[1] Peking University Health Science Center,Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences
[2] Hainan Medical College,Department of Biochemistry
[3] Capital University of Medical Sciences,Department of Biochemistry and Molecular Biology
来源
Biochemistry (Moscow) | 2012年 / 77卷
关键词
E2F1; 8-chloro-adenosine; DNA double-stranded breaks; G2/M arrest; apoptosis;
D O I
暂无
中图分类号
学科分类号
摘要
The E2F1 transcription factor is a well known regulator of cell proliferation and apoptosis, but its role in response to DNA damage is less clear. 8-Chloro-adenosine (8-Cl-Ado), a nucleoside analog, can inhibit proliferation in a variety of human tumor cells. However, it is still elusive how the agent acts on tumors. Here we show that A549 and H1299 cells formed DNA double-strand breaks after 8-Cl-Ado exposure, accompanied by E2F1 upregulation at protein level. Overexpressed wild-type (E2F1-wt) colocalized with double-strand break marker γ-H2AX and promoted G2/M arrest in 8-Cl-Ado-exposed A549 and H1299, while expressed S31A mutant of E2F1 (E2F1-mu) significantly reduced ability to accumulate at sites of DNA damage and G2/M arrest, suggesting that E2F1 is required for activating G2/M checkpoint pathway upon DNA damage. Transfection of either E2F1-wt or E2F1-mu plasmid promoted apoptosis in 8-Cl-Ado-exposed cells, indicating that 8-Cl-Ado may induce apoptosis in E2F1-dependent and E2F1-independent ways. These findings demonstrate that E2F1 plays a crucial role in 8-Cl-Ado-induced G2/M arrest but is dispensable for 8-Cl-Ado-induced apoptosis. These data also suggest that the mechanism of 8-Cl-Ado action is complicated.
引用
收藏
页码:261 / 269
页数:8
相关论文
共 202 条
  • [1] Halgren R. G.(1998)undefined Blood 92 2893-2898
  • [2] Traynor A. E.(2000)undefined Neoplasia 2 441-448
  • [3] Pillay S.(2001)undefined Cancer Res. 61 5474-5479
  • [4] Zell J. L.(2005)undefined Cancer Res. 65 4896-4901
  • [5] Heller K. F.(2004)undefined J. Biol. Chem. 279 40405-40411
  • [6] Krett N. L.(2004)undefined Neoplasia 6 802-812
  • [7] Rosen S. T.(2006)undefined Biochem. Pharmacol. 72 541-550
  • [8] Carlson C. C.(2009)undefined Biochem. Pharmacol. 77 433-443
  • [9] Chinery R.(2009)undefined Biochem. Pharmacol. 77 770-780
  • [10] Burnham L. L.(2002)undefined Nat. Rev. Mol. Cell. Biol. 3 11-20